@article{howard_reckling_egan_dean_2010, title={Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats}, volume={7}, ISSN={["1742-4690"]}, DOI={10.1186/1742-4690-7-2}, abstractNote={The mucosal pathogenesis of HIV has been shown to be an important feature of infection and disease progression. HIV-1 infection causes depletion of intestinal lamina propria CD4+ T cells (LPL), therefore, intestinal CD4+ T cell preservation may be a useful correlate of protection in evaluating vaccine candidates. Vaccine studies employing the cat/FIV and macaque/SIV models frequently use high doses of parenterally administered challenge virus to ensure high plasma viremia in control animals. However, it is unclear if loss of mucosal T cells would occur regardless of initial viral inoculum dose. The objective of this study was to determine the acute effect of viral dose on mucosal leukocytes and associated innate and adaptive immune responses. Cats were vaginally inoculated with a high, middle or low dose of cell-associated and cell-free FIV. PBMC, serum and plasma were assessed every two weeks with tissues assessed eight weeks following infection. We found that irrespective of mucosally administered viral dose, FIV infection was induced in all cats. However, viremia was present in only half of the cats, and viral dose was unrelated to the development of viremia. Importantly, regardless of viral dose, all cats experienced significant losses of intestinal CD4+ LPL and CD8+ intraepithelial lymphocytes (IEL). Innate immune responses by CD56+CD3- NK cells correlated with aviremia and apparent occult infection but did not protect mucosal T cells. CD4+ and CD8+ T cells in viremic cats were more likely to produce cytokines in response to Gag stimulation, whereas aviremic cats T cells tended to produce cytokines in response to Env stimulation. However, while cell-mediated immune responses in aviremic cats may have helped reduce viral replication, they could not be correlated to the levels of viremia. Robust production of anti-FIV antibodies was positively correlated with the magnitude of viremia. Our results indicate that mucosal immune pathogenesis could be used as a rapid indicator of vaccine success or failure when combined with a physiologically relevant low dose mucosal challenge. We also show that innate immune responses may play an important role in controlling viral replication following acute mucosal infection, which has not been previously identified.}, journal={RETROVIROLOGY}, author={Howard, Kristina E. and Reckling, Stacie K. and Egan, Erin A. and Dean, Gregg A.}, year={2010}, month={Jan} } @article{mikkelsen_reckling_egan_dean_2010, title={In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus}, volume={403}, ISSN={["0042-6822"]}, DOI={10.1016/j.virol.2010.04.016}, abstractNote={Regulatory T (Treg) cells are activated and suppress immune responses during infection, and are characterized as CD4+CD25hiFOXP3+. Ex vivo studies demonstrate that Treg cells potentially suppress anti-HIV-1 T cell responses. Lentivirus-induced CD4+CD25hi Treg cells were first described in feline immunodeficiency virus (FIV)-infected cats. In the present study we demonstrate that anti-feline CD25 monoclonal antibody (mAb) therapy depletes Treg cells in FIV-infected cats for 4 weeks and does not exacerbate viral replication or proinflammatory cytokine production. Significant FIV-specific immune responses are revealed in Treg cell-depleted cats. These anti-FIV effector cells exist prior to Treg cell depletion and are not expanded while Treg cells are depleted. Importantly, cats receiving the Treg cell-depleting mAb are able to produce a robust humoral response to new antigen. We propose that short-term in vivo Treg cell depletion during chronic HIV-1 infection could provide a window of opportunity for therapeutic vaccination in individuals with controlled viral replication.}, number={2}, journal={VIROLOGY}, author={Mikkelsen, S. Rochelle and Reckling, Stacie K. and Egan, Erin A. and Dean, Gregg A.}, year={2010}, month={Aug}, pages={163–172} } @article{zimmerman_waters_lyashchenko_nonnecke_armstrong_jacobs_larsen_egan_dean_2009, title={Safety and Immunogenicity of the Mycobacterium tuberculosis Delta lysA Delta panCD Vaccine in Domestic Cats Infected with Feline Immunodeficiency Virus}, volume={16}, ISSN={["1556-6811"]}, DOI={10.1128/CVI.00396-08}, abstractNote={ABSTRACT}, number={3}, journal={CLINICAL AND VACCINE IMMUNOLOGY}, author={Zimmerman, Dawn M. and Waters, W. Ray and Lyashchenko, Konstantin P. and Nonnecke, Brian J. and Armstrong, Douglas L. and Jacobs, William R., Jr. and Larsen, Michelle H. and Egan, Erin and Dean, Gregg A.}, year={2009}, month={Mar}, pages={427–429} }